CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Detalles Bibliográficos
Autores principales: Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188130/
https://www.ncbi.nlm.nih.gov/pubmed/30344934
http://dx.doi.org/10.18632/oncotarget.26134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188130/
https://www.ncbi.nlm.nih.gov/pubmed/30344934
http://dx.doi.org/10.18632/oncotarget.26134

Ejemplares similares